Siemann. In: Rodent Tumor Models in Experimental Cancer Therapy. ed. Kallman. pp. 12-15. Pergamon Press. |
Fareed et al "Human Tumor Regression-Associated Antigenic Determinants" Human Tumor Antigens and Specific Tumor Therapy, 1989, Alan R Liss Inc, NY. pp. 317-334. |
Cysyk et al "Protein Cross-Linking Properties of the Antitumor Agent Inosine Dialdehyde" Cancer Treatment reports 60(5) May 1976, pp. 563-570. |
Shinitzky; "Membrane Fluidity in Malignancy--Adversative and Recuperative"; Bioch. et. Biophys. Acta, 738(1984) 251-261. |
Lider et al.; "Therapeutic Vaccination Against Adjuvant Arthritis Using Autoimmune T Cells Treated with Hydrostatic Pressure"; Proc. Natl. Acad. Sci. USA, 84, pp. 4577-4580, Jul. 1987. |
Ramakrishna et al., "Potentiation of Delayed-Type Hypersensitivity Response to Syngeneic Tumors in Mice Prevaccinated with Cells Modified by Hydrostatic Pressure and Crosslinking"; Can. Immunol. Immunother., 33 (1991) 1-8. |
Richert et al., "Promotion of Tumor Antigenicity in EL-4 Leukemia Cells by Hydrostatic Pressure"; Can. Immunol. Immunother, 22 (1986) 119-124. |
Lider et al., "Vaccination Against Experimental Autoimmune Diseases Using T Lymphocytes Treated with Hydrostatic Pressure"; Ann. N.Y. Acad. Sci., 475 (1986) 267-273. |
Skornick et al., "Active Immunotherapy of Human Solid Tumor with Autologous Cells Treated with Cholesteryl Hemisuccinate"; Cancer, 58, No. 3(1986) 650-654. |